Next 10 |
2024-04-29 15:08:53 ET Summary AbbVie Inc.'s shares dropped last week due to concerns about the erosion of Humira and despite the company beating revenue and EPS expectations. Humira's global sales fell 36% YoY, but AbbVie's other growth products performed well, leading to overall...
2024-04-29 11:00:06 ET Evan Seigerman from BMO Capital issued a price target of $180.00 for ABBV on 2024-04-29 09:49:00. The adjusted price target was set to $180.00. At the time of the announcement, ABBV was trading at $158.5841. The overall price target consensus is at...
2024-04-29 06:08:56 ET Summary On April 26, AbbVie published financial results for the first quarter of 2024, which pleasantly surprised me. Rinvoq sales were about $1.1 billion in the first quarter of 2024, up 59.3% from the previous year. The company's management raised its ...
2024-04-28 13:00:22 ET Orphan drugs -- medicines to treat rare diseases -- from Johnson & Johnson ( NYSE: JNJ ), Roche ( OTCQX:RHHBY ), and AstraZeneca ( NASDAQ: AZN ) will allow these companies to reign as the top 3 orphan drugmakers, by sales, in 2028.... Rea...
2024-04-28 04:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-26 16:07:11 ET By almost any measure, AbbVie (NYSE: ABBV) shares should have risen Friday. The pharmaceutical giant delivered first-quarter sales and earnings results that topped estimates. The decline in sales of multi-indication immunosuppressive drug Humira -- a natural r...
2024-04-26 15:15:13 ET Image source: The Motley Fool. AbbVie (NYSE: ABBV) Q1 2024 Earnings Call Apr 26, 2024 , 9:00 a.m. ET Operator Continue reading For further details see: AbbVie (ABBV) Q1 2024 Earnings Call Transcript
2024-04-26 14:09:10 ET More on AbbVie AbbVie Inc. (ABBV) Q1 2024 Earnings Call Transcript AbbVie's Q1: Positive Surprise AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment AbbVie Q1 report beats Street despite plunging Humira sales ...
2024-04-26 14:04:32 ET This week was one of the heaviest in terms of companies that reported their first quarter earnings. Here is a recap of a few popular names that have reported their results.... Read the full article on Seeking Alpha For further details see: More than ha...
2024-04-26 13:25:32 ET AbbVie Inc. (ABBV) Q1 2024 Earnings Conference Call April 26, 2024 09:00 AM ET Company Participants Liz Shea - Vice President of Investor Relations Rick Gonzalez - Chairman of the Board & Chief Executive Officer Rob Michael - President ...
News, Short Squeeze, Breakout and More Instantly...
2024-04-29 11:00:06 ET Evan Seigerman from BMO Capital issued a price target of $180.00 for ABBV on 2024-04-29 09:49:00. The adjusted price target was set to $180.00. At the time of the announcement, ABBV was trading at $158.5841. The overall price target consensus is at...
Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...
2024-04-28 04:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...